119
Participants
Start Date
October 28, 2020
Primary Completion Date
July 20, 2021
Study Completion Date
July 20, 2021
AZD8233
PCSK9-targeted ASO for the reduction of circulating levels of LDL-C.
Placebo
Placebo solution
Research Site, Frederiksberg
Research Site, Herlev
Research Site, Roskilde
Research Site, Trebišov
Research Site, Aarhus N
Research Site, Viborg
Research Site, New Windsor
Research Site, Greensboro
Research Site, Jacksonville
Research Site, Pembroke Pines
Research Site, Inverness
Research Site, Cincinnati
Research Site, Indianapolis
Research Site, Fargo
Research Site, Meridian
Research Site, Bratislava
Research Site, Roseville
Research Site, Bratislava
Research Site, Rožňava
Lead Sponsor
AstraZeneca
INDUSTRY